Copyright Reports & Markets. All rights reserved.

Global Psoriatic Arthritis (PsA) Treatment Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Psoriatic Arthritis (PsA) Treatment Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Nonsteriodal Anti-inflammatory Drugs
      • 1.4.3 Disease Modifying Antirheumatic Drugs
      • 1.4.4 Biologics
    • 1.5 Market by Application
      • 1.5.1 Global Psoriatic Arthritis (PsA) Treatment Market Share by Application (2014-2025)
      • 1.5.2 Hospitals
      • 1.5.3 Clinics
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Psoriatic Arthritis (PsA) Treatment Market Size
    • 2.2 Psoriatic Arthritis (PsA) Treatment Growth Trends by Regions
      • 2.2.1 Psoriatic Arthritis (PsA) Treatment Market Size by Regions (2014-2025)
      • 2.2.2 Psoriatic Arthritis (PsA) Treatment Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Psoriatic Arthritis (PsA) Treatment Market Size by Manufacturers
      • 3.1.1 Global Psoriatic Arthritis (PsA) Treatment Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Psoriatic Arthritis (PsA) Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Psoriatic Arthritis (PsA) Treatment Key Players Head office and Area Served
    • 3.3 Key Players Psoriatic Arthritis (PsA) Treatment Product/Solution/Service
    • 3.4 Date of Enter into Psoriatic Arthritis (PsA) Treatment Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Psoriatic Arthritis (PsA) Treatment Market Size by Type (2014-2019)
    • 4.2 Global Psoriatic Arthritis (PsA) Treatment Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Psoriatic Arthritis (PsA) Treatment Market Size (2014-2019)
    • 5.2 Psoriatic Arthritis (PsA) Treatment Key Players in United States
    • 5.3 United States Psoriatic Arthritis (PsA) Treatment Market Size by Type
    • 5.4 United States Psoriatic Arthritis (PsA) Treatment Market Size by Application

    6 Europe

    • 6.1 Europe Psoriatic Arthritis (PsA) Treatment Market Size (2014-2019)
    • 6.2 Psoriatic Arthritis (PsA) Treatment Key Players in Europe
    • 6.3 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Type
    • 6.4 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Application

    7 China

    • 7.1 China Psoriatic Arthritis (PsA) Treatment Market Size (2014-2019)
    • 7.2 Psoriatic Arthritis (PsA) Treatment Key Players in China
    • 7.3 China Psoriatic Arthritis (PsA) Treatment Market Size by Type
    • 7.4 China Psoriatic Arthritis (PsA) Treatment Market Size by Application

    8 Japan

    • 8.1 Japan Psoriatic Arthritis (PsA) Treatment Market Size (2014-2019)
    • 8.2 Psoriatic Arthritis (PsA) Treatment Key Players in Japan
    • 8.3 Japan Psoriatic Arthritis (PsA) Treatment Market Size by Type
    • 8.4 Japan Psoriatic Arthritis (PsA) Treatment Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Psoriatic Arthritis (PsA) Treatment Market Size (2014-2019)
    • 9.2 Psoriatic Arthritis (PsA) Treatment Key Players in Southeast Asia
    • 9.3 Southeast Asia Psoriatic Arthritis (PsA) Treatment Market Size by Type
    • 9.4 Southeast Asia Psoriatic Arthritis (PsA) Treatment Market Size by Application

    10 India

    • 10.1 India Psoriatic Arthritis (PsA) Treatment Market Size (2014-2019)
    • 10.2 Psoriatic Arthritis (PsA) Treatment Key Players in India
    • 10.3 India Psoriatic Arthritis (PsA) Treatment Market Size by Type
    • 10.4 India Psoriatic Arthritis (PsA) Treatment Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Psoriatic Arthritis (PsA) Treatment Market Size (2014-2019)
    • 11.2 Psoriatic Arthritis (PsA) Treatment Key Players in Central & South America
    • 11.3 Central & South America Psoriatic Arthritis (PsA) Treatment Market Size by Type
    • 11.4 Central & South America Psoriatic Arthritis (PsA) Treatment Market Size by Application

    12 International Players Profiles

    • 12.1 Pfizer
      • 12.1.1 Pfizer Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Psoriatic Arthritis (PsA) Treatment Introduction
      • 12.1.4 Pfizer Revenue in Psoriatic Arthritis (PsA) Treatment Business (2014-2019)
      • 12.1.5 Pfizer Recent Development
    • 12.2 Johnson & Johnson
      • 12.2.1 Johnson & Johnson Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Psoriatic Arthritis (PsA) Treatment Introduction
      • 12.2.4 Johnson & Johnson Revenue in Psoriatic Arthritis (PsA) Treatment Business (2014-2019)
      • 12.2.5 Johnson & Johnson Recent Development
    • 12.3 AbbVie
      • 12.3.1 AbbVie Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Psoriatic Arthritis (PsA) Treatment Introduction
      • 12.3.4 AbbVie Revenue in Psoriatic Arthritis (PsA) Treatment Business (2014-2019)
      • 12.3.5 AbbVie Recent Development
    • 12.4 Novartis
      • 12.4.1 Novartis Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Psoriatic Arthritis (PsA) Treatment Introduction
      • 12.4.4 Novartis Revenue in Psoriatic Arthritis (PsA) Treatment Business (2014-2019)
      • 12.4.5 Novartis Recent Development
    • 12.5 UCB
      • 12.5.1 UCB Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Psoriatic Arthritis (PsA) Treatment Introduction
      • 12.5.4 UCB Revenue in Psoriatic Arthritis (PsA) Treatment Business (2014-2019)
      • 12.5.5 UCB Recent Development
    • 12.6 Roche
      • 12.6.1 Roche Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Psoriatic Arthritis (PsA) Treatment Introduction
      • 12.6.4 Roche Revenue in Psoriatic Arthritis (PsA) Treatment Business (2014-2019)
      • 12.6.5 Roche Recent Development
    • 12.7 Bristol-Myers Squibb
      • 12.7.1 Bristol-Myers Squibb Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Psoriatic Arthritis (PsA) Treatment Introduction
      • 12.7.4 Bristol-Myers Squibb Revenue in Psoriatic Arthritis (PsA) Treatment Business (2014-2019)
      • 12.7.5 Bristol-Myers Squibb Recent Development
    • 12.8 Eli Lilly
      • 12.8.1 Eli Lilly Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Psoriatic Arthritis (PsA) Treatment Introduction
      • 12.8.4 Eli Lilly Revenue in Psoriatic Arthritis (PsA) Treatment Business (2014-2019)
      • 12.8.5 Eli Lilly Recent Development
    • 12.9 Amgen
      • 12.9.1 Amgen Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Psoriatic Arthritis (PsA) Treatment Introduction
      • 12.9.4 Amgen Revenue in Psoriatic Arthritis (PsA) Treatment Business (2014-2019)
      • 12.9.5 Amgen Recent Development
    • 12.10 AstraZeneca
      • 12.10.1 AstraZeneca Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Psoriatic Arthritis (PsA) Treatment Introduction
      • 12.10.4 AstraZeneca Revenue in Psoriatic Arthritis (PsA) Treatment Business (2014-2019)
      • 12.10.5 AstraZeneca Recent Development
    • 12.11 Celgene

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      In 2018, the global Psoriatic Arthritis (PsA) Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Psoriatic Arthritis (PsA) Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Psoriatic Arthritis (PsA) Treatment development in United States, Europe and China.

      The key players covered in this study
      Pfizer
      Johnson & Johnson
      AbbVie
      Novartis
      UCB
      Roche
      Bristol-Myers Squibb
      Eli Lilly
      Amgen
      AstraZeneca
      Celgene

      Market segment by Type, the product can be split into
      Nonsteriodal Anti-inflammatory Drugs
      Disease Modifying Antirheumatic Drugs
      Biologics

      Market segment by Application, split into
      Hospitals
      Clinics
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Psoriatic Arthritis (PsA) Treatment status, future forecast, growth opportunity, key market and key players.
      To present the Psoriatic Arthritis (PsA) Treatment development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Psoriatic Arthritis (PsA) Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now